These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22259215)

  • 21. High-volume workflow and performance comparisons for Chlamydia trachomatis and Neisseria gonorrhoeae testing using automated molecular platforms.
    Frontzek A; Aretzweiler G; Winkens D; Duncan D; Marlowe EM
    BMC Infect Dis; 2019 Sep; 19(1):797. PubMed ID: 31510949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of a Rapid Diagnostic for Chlamydia trachomatis and Neisseria gonorrhoeae for Women in the Emergency Department Can Improve Clinical Management: Report of a Randomized Clinical Trial.
    Gaydos CA; Ako MC; Lewis M; Hsieh YH; Rothman RE; Dugas AF
    Ann Emerg Med; 2019 Jul; 74(1):36-44. PubMed ID: 30392736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Head-to-head comparison of second-generation nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae on urine samples from female subjects and self-collected vaginal swabs.
    Chernesky M; Jang D; Gilchrist J; Hatchette T; Poirier A; Flandin JF; Smieja M; Ratnam S
    J Clin Microbiol; 2014 Jul; 52(7):2305-10. PubMed ID: 24696024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the Roche cobas® CT/NG test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in male urine.
    Taylor SN; Liesenfeld O; Lillis RA; Body BA; Nye M; Williams J; Eisenhut C; Hook EW; Van Der Pol B
    Sex Transm Dis; 2012 Jul; 39(7):543-9. PubMed ID: 22706217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae based on cross-priming amplification.
    Yu B; An Y; Xu G; Shan H
    Lett Appl Microbiol; 2016 May; 62(5):399-403. PubMed ID: 26949934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the APTIMA CT and GC assays with the APTIMA combo 2 assay, the Abbott LCx assay, and direct fluorescent-antibody and culture assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
    Boyadzhyan B; Yashina T; Yatabe JH; Patnaik M; Hill CS
    J Clin Microbiol; 2004 Jul; 42(7):3089-93. PubMed ID: 15243065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men.
    Schachter J; Moncada J; Liska S; Shayevich C; Klausner JD
    Sex Transm Dis; 2008 Jul; 35(7):637-42. PubMed ID: 18520976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of self-collected samples in contrast to practitioner-collected samples for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by polymerase chain reaction among women living in remote areas.
    Knox J; Tabrizi SN; Miller P; Petoumenos K; Law M; Chen S; Garland SM
    Sex Transm Dis; 2002 Nov; 29(11):647-54. PubMed ID: 12438900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the APTIMA Combo 2 Assay using self-administered vaginal swabs for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
    Crucitti T; De Deken B; Smet H; Cuylaerts V; Abdellati S; Vuylsteke B
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):385-6. PubMed ID: 23598167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The infections by Chlamydia trachomatis and Neisseria gonorrhoeae].
    Kanoh Y
    Rinsho Byori; 2002 Nov; Suppl 123():57-61. PubMed ID: 12652791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the Hologic Aptima Combo 2 Assay for Detection of Neisseria gonorrhoeae from Joint Fluid Specimens.
    Alexander DC; Taylor RM; Martin I; Adam H; Lagacé-Wiens P; Pieroni P; Karlowsky JA; Van Caeseele P
    J Clin Microbiol; 2022 Apr; 60(4):e0253021. PubMed ID: 35317619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No widespread dissemination of
    Cole MJ; Davis GS; Fifer H; Saunders JM; Unemo M; Hadad R; Roberts DJ; Fazal M; Day MJ; Minshull J; Muir P; Horner PJ; Gill NO; Folkard K
    Sex Transm Infect; 2022 Aug; 98(5):366-370. PubMed ID: 34510008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between Aptima® assays (Hologic) and the CoBAS® 6800 system (Roche) for the diagnosis of sexually transmitted infections caused by Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium.
    Barrientos-Durán A; de Salazar A; Fuentes-López A; Serrano-Conde E; Espadafor B; Chueca N; Álvarez-Estévez M; Garcia F
    Eur J Clin Microbiol Infect Dis; 2021 Jun; 40(6):1337-1342. PubMed ID: 33492527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitivity, specificity, inclusivity and exclusivity of the updated Aptima Combo 2 assay, which provides detection coverage of the new diagnostic-escape Chlamydia trachomatis variants.
    Unemo M; Hansen M; Hadad R; Puolakkainen M; Westh H; Rantakokko-Jalava K; Thilesen C; Cole MJ; Boiko I; Lan PT; Golparian D; Ito S; Sundqvist M
    BMC Infect Dis; 2020 Jun; 20(1):419. PubMed ID: 32546213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of replacing the existing diagnostic strategy for Neisseria gonorrhoeae and Chlamydia trachomatis infections with sole molecular testing of urine specimens in a sexually transmitted infection clinic setting.
    Ho MK; Lo JY; Lo AC; Cheng FK; Chan FK
    Sex Transm Infect; 2009 Sep; 85(5):322-5. PubMed ID: 19406739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First report of performance of the Versant CT/GC DNA 1.0 assay (kPCR) for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
    Kerndt PR; Ferrero DV; Aynalem G; Monga D; Wang S; Zhang N; Wong C; Liggins M; Meng Q
    J Clin Microbiol; 2011 Apr; 49(4):1347-53. PubMed ID: 21307209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by strand displacement amplification and relevance of the amplification control for use with vaginal swab specimens.
    Cosentino LA; Landers DV; Hillier SL
    J Clin Microbiol; 2003 Aug; 41(8):3592-6. PubMed ID: 12904360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay.
    Ginocchio CC; Chapin K; Smith JS; Aslanzadeh J; Snook J; Hill CS; Gaydos CA
    J Clin Microbiol; 2012 Aug; 50(8):2601-8. PubMed ID: 22622447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Screening of Neisseria gonorrhoeae and Chlamydia trachomatis using techniques of self collected vaginal sample in young women].
    Conejero C; Cannoni G; Merino PM; Bollmann J; Hidalgo C; Castro M; Schulin-Zeuthen C
    Rev Chilena Infectol; 2013 Oct; 30(5):489-93. PubMed ID: 24248162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An assessment of the Roche Amplicor Chlamydia trachomatis/Neisseria gonorrhoeae multiplex PCR assay in routine diagnostic use on a variety of specimen types.
    Leslie DE; Azzato F; Ryan N; Fyfe J
    Commun Dis Intell Q Rep; 2003; 27(3):373-9. PubMed ID: 14510065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.